Recent Price Movement and Market Context
On the day the new low was recorded, Poly Medicure’s stock underperformed its sector by 0.93%, closing with a day change of -1.31%. This decline extended a two-day losing streak during which the stock has fallen by 4.31%. The share price now trades below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling persistent bearish momentum.
The broader market environment has also been challenging. The Sensex opened flat but subsequently declined by 389.96 points, or 0.51%, settling at 81,830.52. Notably, the Sensex itself is trading below its 50-day moving average, although the 50DMA remains above the 200DMA, indicating mixed signals for the overall market trend.
Long-Term Performance and Valuation Metrics
Poly Medicure’s one-year performance starkly contrasts with the broader market benchmark. The stock has delivered a negative return of 41.42% over the past year, while the Sensex has gained 9.67% during the same period. The 52-week high for the stock was Rs.2936.7, highlighting the extent of the recent decline.
Despite the share price drop, the company’s profits have shown some growth, with an 11.9% increase over the last year. However, this has not translated into positive returns for shareholders, as reflected in the company’s PEG ratio of 3.1, which suggests that the stock’s price is not aligned favourably with its earnings growth.
Strong fundamentals, steady climb upward! This Large Cap from Telecommunication sector earned its Reliable Performer badge through consistent execution. Safety meets solid returns here!
- - Reliable Performer certified
- - Consistent execution proven
- - Large Cap safety pick
Financial Ratios and Profitability Analysis
The company’s operating profit has grown at an annual rate of 17.77% over the last five years, which is considered modest within the healthcare services sector. However, recent quarterly results have shown a decline in profitability. The Profit After Tax (PAT) for the quarter ending December 2025 stood at Rs.75.86 crores, down by 11.0% compared to the previous period.
Further, the operating profit to net sales ratio for the quarter was at a low 22.52%, indicating pressure on margins. The debtor turnover ratio for the half-year was recorded at 4.02 times, the lowest in recent periods, suggesting slower collection cycles which could impact liquidity.
Return on Equity (ROE) stands at 12.4%, which, combined with a Price to Book Value of 4.4, points to a relatively expensive valuation. Despite this, the stock is trading at a discount compared to its peers’ average historical valuations, reflecting the market’s cautious stance.
Sector Position and Market Capitalisation
Poly Medicure holds a significant position within the healthcare services sector, with a market capitalisation of Rs.12,790 crores. It is the second largest company in the sector, trailing only Lenskart Solutions, and accounts for 11.29% of the sector’s total market value. The company’s annual sales of Rs.1,781.58 crores represent 16.54% of the industry’s total sales, underscoring its sizeable footprint.
Institutional investors hold a substantial 23.24% stake in the company, indicating a level of confidence from entities with extensive analytical resources. The company maintains a low average debt-to-equity ratio of zero, reflecting a conservative capital structure with minimal leverage.
Poly Medicure Ltd or something better? Our SwitchER feature analyzes this small-cap Healthcare Services stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Mojo Score and Rating Update
According to MarketsMOJO’s assessment, Poly Medicure currently holds a Mojo Score of 30.0 and a Mojo Grade of Sell, an upgrade from its previous Strong Sell rating as of 11 Feb 2026. The market cap grade is rated at 3, reflecting its large-cap status but tempered by recent performance metrics.
The downgrade in sentiment is consistent with the stock’s underperformance relative to the BSE500 index over the last three years, one year, and three months. This trend highlights the challenges the company faces in delivering returns that meet or exceed broader market benchmarks.
Summary of Key Concerns
The stock’s fall to Rs.1240, its lowest level in 52 weeks, is underpinned by a combination of factors including subdued profit growth, declining quarterly earnings, and valuation concerns. The company’s profitability ratios have weakened, and its share price has not kept pace with sector or market indices. Despite a strong market position and low leverage, these financial indicators have contributed to the cautious market stance.
Poly Medicure’s current trading below all major moving averages further emphasises the prevailing negative momentum. The stock’s underperformance relative to the Sensex and sector peers over multiple time frames adds to the context of its recent price decline.
Conclusion
Poly Medicure Ltd’s stock reaching a 52-week low of Rs.1240 reflects a period of subdued market confidence and financial headwinds. While the company maintains a significant presence in the healthcare services sector with a conservative capital structure, recent earnings and valuation metrics have weighed on its share price. The stock’s performance relative to broader indices and sector benchmarks highlights the challenges faced in recent periods.
Only Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Start Today
